| A | B | C | |
|---|---|---|---|
| 1 | Main | ||
| 2 | Brand Name | R1439 | |
| 3 | Generic Name | aleglitazar | |
| 4 | Indication | Diabetes with recent CV event | |
| 5 | Mechanism | PPAR co-agonist | |
| 6 | Clinical Trials | ||
| 7 | Phase II SYNCHRONY - Published in Lancet |
| A | B | C | |
|---|---|---|---|
| 1 | Main | ||
| 2 | Brand Name | R1439 | |
| 3 | Generic Name | aleglitazar | |
| 4 | Indication | Diabetes with recent CV event | |
| 5 | Mechanism | PPAR co-agonist | |
| 6 | Clinical Trials | ||
| 7 | Phase II SYNCHRONY - Published in Lancet |
Martin Shkreli